Download PDF
Semin Musculoskelet Radiol 1999; 3(2): 197-205
DOI: 10.1055/s-2008-1080063
© 1999 by Thieme Medical Publishers, Inc.

MR Imaging in the Follow-Up Evaluation of Aggressive Soft Tissue Tumors

Lorraine G. Shapeero1 , Daniel Vanel2
  • 1Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, and Department of Radiology, Walter Reed Army Medical Center, Washington, District of Columbia
  • 2Department of Radiology, Institut Gustave Roussy, Villejuif France
Further Information

Publication History

Publication Date:
18 June 2008 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Although newer imaging techniques aid in the diagnosis of soft tissue sarcomas and current surgical procedures and adjunct therapy decrease the incidence of their recurrences when patients are referred to oncologic centers, the majority of these tumors are suboptimally evaluated in general practice with frequent recurrences. Close surveillance of these patients is necessary for early recognition and treatment of recurrent disease. This article describes an organized, stepwise magnetic resonance imaging evaluation of these patients after surgery and radiation therapy. The initial sequence should be T2-weighted. Low signal intensity or diffuse high signal intensity without mass on T2-weighted sequence excludes recurrence in 99% of patients. A high signal intensity mass, however, should be studied with bolus injection of contrast medium. Although standard contrast-enhanced MR imaging differentiates the non-enhancing hygroma or hematoma from the enhancing recurrence or pseudotumor, dynamic contrast-enhanced MR imaging is required to distinguish the rapidly enhancing recurrent tumor from the slowly enhancing pseudotumor of inflammation.

KEYWORDS

Soft tissue, neoplasms - soft tissue, recurrence - magnetic resonance (MR), rapid imaging - soft tissue, MR - sarcoma, soft tissue